2nd try today so far is positive despite being down1 it has ensured the stock hasnt risen too quickly2 it has tested 3.1 and bounced of it3 its NOT attracting large selling
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%